Uroalerts Men's Health Weekly

January 13, 2025

Videos

Peer-to-Peer Clinical Conversations

AUA's Surgical Guidelines for BPH: From Patient Assessment to Procedure Selection, Journal Club - Rashid Sayyid & Zachary Klaassen

Zachary Klaassen

Rashid Sayyid and Zach Klaassen discuss the AUA's updated guidelines for surgical therapy of BPH-related lower urinary tract symptoms.

Traction Therapy Helps Men Regain Penile Length After Prostate Cancer Treatment - Amy Pearlman

Amy Pearlman

Amy Pearlman discusses penile traction therapy using the RestoreX device, a second-generation technology designed to address penile length changes after prostate cancer treatment.

Beyond the Abstracts

Pharmacological Therapies for Male Infertility - Beyond the Abstract

Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

Current drawbacks and future perspectives in the diagnosis and treatment of male factor infertility, with a focus on FSH treatment: an expert opinion.

Is There a Role for Hormonal Therapy in Men with Oligoasthenoteratozoospermia (OAT)?

The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.

Pharmacological Therapies for Male Infertility - Beyond the Abstract

Erectile Dysfunction

Comparison of the effectiveness of 2 shockwave therapy protocols for the treatment of vascular erectile dysfunction: a randomized, multicenter, open-label, noninferiority, phase 4 clinical trial.

Association between five novel anthropometric indices and erectile dysfunction in US adults from NHANES database.

The association between comprehensive dietary antioxidant index and erectile dysfunction in adult men: a cross-sectional study from the 2001-2004 U.S. National Health and Nutrition Examination Survey.

The associations among platelet count, mean platelet volume, and erectile dysfunction: an observational and Mendelian randomization study.

Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract

BPH - Benign Prostatic Enlargement

Innovative Use of RADA16 Self-Assembling Peptide (PuraBond®) as a Hemostatic Agent in Holmium Laser Enucleation of the Prostate (HoLEP): A Safety and Feasibility Study.

MRI-Derived Transition Zone Index Is Highly Predictive of Urodynamic Bladder Outlet Obstruction Prior to Holmium Laser Enucleation of the Prostate.

Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia.

The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia.

Technological innovation of HoLEP: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Reimagining Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia Treatment: A New Approach to First-line Interventional Therapy.

Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia-A Multicenter Study.

Prospective Observational Study on the Efficacy and Tolerability of a Complex of Phytochemicals Versus Dutasteride in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia - Beyond the Abstract

Predictors of Achieving a Minimal Clinically Important Difference in Lower Urinary Tract Symptoms 3 Months after Rezum Therapy - Beyond the Abstract

Penile & Urethral Cancers

Comparison of antegrade and retrograde laparoscopic bilateral inguinal lymphadenectomy for penile cancer.

Immunotherapy in Penile Cancer: A Systematic Review.

Testicular Cancer

The effects of regular exercise on cognitive and cardiometabolic health in testicular cancer survivors subjected to platinum-based chemotherapy.

Can Multiparametric Ultrasound Analysis Predict Malignancy in Testes? An 11-Year Single Center Experience with Testicular Masses.

Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sample.

Racial/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992-2021.

Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review - Beyond the Abstract

High-Dose Chemotherapy as Initial Salvage Chemotherapy in Patients with Relapsed or Refractory Testicular Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract

Prostate Cancer

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC

Contemporary prostate cancer radiation therapy trials may underestimate the risk of biochemical recurrence.

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth.

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.

Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET/CT.

Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer.

Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.

Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer.

Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer.

Novel hormonal agents in men with metastatic castration resistant prostate cancer and reduced performance status: Experiences of a specialized single center.

Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients.

Impact of Intraoperative Opioid Use and a Combined Anesthesia Regimen in Patients Undergoing Radical Prostatectomy for Prostate Cancer in a Single-Center Cohort.

Enhancing Data Completeness in Early Detection Pathway of Prostate Cancer: Integration of a Dashboard-Driven Feedback Tool to Improve Quality of Care.

Current Clinical Applications of PSMA-PET for Prostate Cancer Diagnosis, Staging, and Treatment.

The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients-A Systematic Review and Meta-Analysis.

Molecular Detection of Lymph Node Metastases with One-Step Nucleic Acid Amplification (OSNA) Pooling in Prostate Cancer: The POPCORN Study.

Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy.

Clinical Feasibility of 3-D Acoustic Radiation Force Impulse (ARFI) Imaging for Targeted Prostate Biopsy Guidance.

Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer.

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis.

Prostate Cancer Risk Prediction Model Using Clinical and Magnetic Resonance Imaging-Related Findings: Impact of Combining Lesions' Locations and Apparent Diffusion Coefficient Values.

PIRADS 3 MRI lesions: are biopsies still necessary?

Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium.

Current Status of Sequential Treatment for Castration-resistant Prostate Cancer: A Retrospective Analysis.

Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing.

Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System.

Advances in Prostate Cancer Treatment: Radionuclide Therapy for Prostate Cancer - Beyond the Abstract

Small-Molecule Disruption of Androgen Receptor-Dependent Chromatin Clusters - Beyond the Abstract

Prostate-Specific Antigen Kinetics after Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Scoping Review and Meta-Analysis - Beyond the Abstract

Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and Without DNA Repair Defects - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC